ArticleFrontiers in immunology2023

Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma.

Zhuochao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.